Michael Forbes, CEO of Adastra, stated in his Original push launch: “Harm reduction is really a critically vital and mainstream matter, and we are being within the forefront of drug regulations through the board.” May sell substandard and falsified prescription drugs designed or dispersed less than unregulated and perhaps unsafe techniques,